These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8469867)

  • 41. [Inducing labor with Propess].
    Tsernev T
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():3-4. PubMed ID: 19708186
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cervical maturation and induction of labor with PgE2 gel. Authors' experience].
    Carta G; Vigilante M; Di Cesare S; Mascaretti G; Caserta D; Moscarini M
    Minerva Ginecol; 1997 Oct; 49(10):427-32. PubMed ID: 9463175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Remodelling of connective tissue of the cervix during pregnancy. An important process for labor onset and progress].
    Ekman-Ordeberg G; Malmström A
    Lakartidningen; 1998 Sep; 95(38):4097-100. PubMed ID: 9772804
    [No Abstract]   [Full Text] [Related]  

  • 44. [Obstetrical prognosis of labour induction with mifepristone after 41 weeks of gestation].
    Gallot D; de Lapasse C; Houlle C; Sapin V; Laurichesse-Delmas H; Saulnier JP; Vanlieferinghen P; Vendittelli F; Ughetto S; Lémery D
    Gynecol Obstet Fertil; 2004 Sep; 32(9):708-12. PubMed ID: 15380749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Could antiprogesterones be used as alternative cervical ripening agents?
    Johnson N; Bryce FC
    Am J Obstet Gynecol; 1990 Mar; 162(3):688-90. PubMed ID: 2316569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cervical maturation by repeated applications of prostaglandin E2 gel. 186 cases].
    Panel P; Bascou V; de Meeus JB; Magnin G
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(4):386-94. PubMed ID: 9265064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of labor.
    Reichler A; Romem Y; Divon MY
    Curr Opin Obstet Gynecol; 1995 Dec; 7(6):432-6. PubMed ID: 8620075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized comparison of oral mifepristone to intravenous oxytocin for labor induction in women with prelabor rupture of membranes beyond 36 weeks' gestation.
    Wing DA; Guberman C; Fassett M
    Am J Obstet Gynecol; 2005 Feb; 192(2):445-51. PubMed ID: 15695985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
    Heikinheimo O; Leminen R; Suhonen S
    Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procedures on handling mifepristone (RU 486) in France.
    Sarrut B; Doreau C
    Hosp Pharm; 1990 Jul; 25(7):655-8. PubMed ID: 10105331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A new antiprogestational compound, mifepristone (RU-486)].
    Parisi C; Steffe M
    Patol Clin Ostet Ginecol; 1988; 16(4):291-4. PubMed ID: 12345008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
    Väyrynen W; Heikinheimo O; Nuutila M
    Acta Obstet Gynecol Scand; 2007; 86(6):701-5. PubMed ID: 17520402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RU-486. Anti-choice extremists block HIV drug research.
    Szalavitz M
    Notes Undergr; 1999; (No 39):1, 3-4, 7. PubMed ID: 11366781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uses of RU 486: a clinical update.
    Elia D
    IPPF Med Bull; 1986 Oct; 20(5):1-2. PubMed ID: 12341333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mifepristone for induction of labor].
    Su H; Li E; Weng L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):676-80. PubMed ID: 9387530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mifepristone--a new antiprogesterone in obstetrics and gynecology].
    Aschkenazi S; Levy T; Ben-Rafael Z
    Harefuah; 2001 May; 140(5):429-34. PubMed ID: 11419069
    [No Abstract]   [Full Text] [Related]  

  • 58. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
    Ramondetta LM; Johnson AJ; Sun CC; Atkinson N; Smith JA; Jung MS; Broaddus R; Iyer RB; Burke T
    Cancer; 2009 May; 115(9):1867-74. PubMed ID: 19241422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Inducing labor applying intra-cervical prostaglandin E vaginal tablets].
    Minkov R; Popova A; Kovachev E; Tsvetkova S; Protopopov F; Pencheva M
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():13-5. PubMed ID: 19708188
    [No Abstract]   [Full Text] [Related]  

  • 60. RU 486 abortions.
    Henrion R
    Nature; 1989 Mar; 338(6211):110. PubMed ID: 2918933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.